Compounds > cytarabine

cytarabine and Diathesis

cytarabine has been researched along with Diathesis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, R; Li, YC; Wu, B; Yang, W; Yao, K; Zhang, GJ; Zhang, R1
Allen, PD; Castenskiold, EC; Coldwell, RD; Collins, PW; Goldstone, AH; Kelsey, SM; Makin, HL; Newland, AC; Side, LE1
Dann, EJ; Gillis, S; Rund, D1
Björkholm, M; Gruber, A; Hansson, M; Steingrimsdottir, H; Svensson, A1
Alegre, A; Algora, M; García Plaza, I; Llanos, ML; Lozano, M; Padilla, B; Peñalver, MA; Pérez-Pons, C1

Other Studies

5 other study(ies) available for cytarabine and Diathesis

ArticleYear
The OPN gene polymorphism confers the susceptibility and response to Ara-C based chemotherapy in Chinese AML patients.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015, Volume: 35, Issue:1

    Topics: Adult; Alleles; Antimetabolites, Antineoplastic; Apoptosis; Cell Line, Tumor; China; Cytarabine; Disease Susceptibility; Female; Genotype; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Osteopontin; Polymorphism, Single Nucleotide; Transfection

2015
Functional hyperactivity of monocytes after bone marrow transplantation: possible relevance for the development of post-transplant complications or relapse.
    Bone marrow transplantation, 1995, Volume: 15, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biopterins; Bone Marrow Transplantation; Busulfan; Carmustine; Cells, Cultured; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Susceptibility; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Leukemia; Lymphoma; Male; Melphalan; Middle Aged; Monocytes; Neopterin; Podophyllotoxin; Respiratory Burst; Superoxides; Tumor Necrosis Factor-alpha; Whole-Body Irradiation

1995
Selective discharge of patients with acute myeloid leukemia during chemotherapy-induced neutropenia.
    American journal of hematology, 1996, Volume: 51, Issue:1

    Topics: Acute Disease; Adult; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Catheterization, Central Venous; Cross Infection; Cytarabine; Daunorubicin; Disease Susceptibility; Etoposide; Female; Fever; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Neutropenia; Patient Discharge; Safety; Treatment Outcome

1996
Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
    Haematologica, 2000, Volume: 85, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Breast Neoplasms; Carmustine; Cell Lineage; Combined Modality Therapy; Cytarabine; Disease Susceptibility; Female; Graft Survival; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infections; Lymphocyte Count; Lymphocyte Subsets; Lymphopenia; Male; Melphalan; Middle Aged; Podophyllotoxin; Sweden; Transplantation Conditioning; Transplantation, Autologous

2000
[Focal hepato-splenic mycosis caused by Trichosporon beigelii in a patient with acute leukemia].
    Sangre, 1991, Volume: 36, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease Susceptibility; Hepatitis; Humans; Immunocompromised Host; Leukemia, Promyelocytic, Acute; Male; Mycoses; Opportunistic Infections; Splenic Diseases; Trichosporon

1991